E J Wagena

Summary

Affiliation: Solvay Pharmaceuticals
Country: The Netherlands

Publications

  1. ncbi Are patients with COPD psychologically distressed?
    E J Wagena
    Pulmonary Rehabilitation Centre, Hornerheide, Horn, The Netherlands
    Eur Respir J 26:242-8. 2005
  2. ncbi Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease
    E J Wagena
    Department of General Practice, Maastricht University, The Netherlands
    Arch Intern Med 165:2286-92. 2005
  3. ncbi A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Addiction 101:1656-61. 2006
  4. ncbi Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis
    E J Wagena
    Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Addiction 100:317-26. 2005
  5. ncbi The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review
    E J Wagena
    Care and Public Health Research Institute, Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Respir Med 98:805-15. 2004
  6. ncbi Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, 3200 MD Maastricht, The Netherlands
    Addiction 100:1012-20. 2005
  7. ncbi Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
    E J Wagena
    Maastricht University, Care and Public Health Research Institute Caphri, Department of General Practice, Maastricht, The Netherlands
    J Med Ethics 31:307. 2005
  8. ncbi [The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data]
    M C Willemsen
    STIVORO voor een rookvrije toekomst, Postbus 16 070, 2500 BB Den Haag
    Ned Tijdschr Geneeskd 147:922-7. 2003

Detail Information

Publications8

  1. ncbi Are patients with COPD psychologically distressed?
    E J Wagena
    Pulmonary Rehabilitation Centre, Hornerheide, Horn, The Netherlands
    Eur Respir J 26:242-8. 2005
    ....
  2. ncbi Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease
    E J Wagena
    Department of General Practice, Maastricht University, The Netherlands
    Arch Intern Med 165:2286-92. 2005
    ..No clinical trial has studied the efficacy of bupropion hydrochloride and nortriptyline hydrochloride for smoking cessation in this patient population, to our knowledge...
  3. ncbi A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Addiction 101:1656-61. 2006
    ..For 6 months, participants in the intervention group could apply for reimbursement and received information regarding the reimbursed SCT. Participants in the control group received no reimbursement or information...
  4. ncbi Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis
    E J Wagena
    Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Addiction 100:317-26. 2005
    ..The objective of this paper is to evaluate the efficacy of nortriptyline for smoking cessation compared to placebo and bupropion sustained release...
  5. ncbi The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review
    E J Wagena
    Care and Public Health Research Institute, Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Respir Med 98:805-15. 2004
    ..Present evidence suggests that the most effective intervention for prolonged smoking cessation in patients with COPD is the combination of nicotine replacement therapy, coupled with an intensive, prolonged relapse prevention programme...
  6. ncbi Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, 3200 MD Maastricht, The Netherlands
    Addiction 100:1012-20. 2005
    ..To increase the number of successful quitters, we assessed whether financial reimbursement for SCT would encourage the use of SCT and would as a result increase the 6-month point abstinence rate...
  7. ncbi Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
    E J Wagena
    Maastricht University, Care and Public Health Research Institute Caphri, Department of General Practice, Maastricht, The Netherlands
    J Med Ethics 31:307. 2005
  8. ncbi [The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data]
    M C Willemsen
    STIVORO voor een rookvrije toekomst, Postbus 16 070, 2500 BB Den Haag
    Ned Tijdschr Geneeskd 147:922-7. 2003
    ..To obtain an overview of data from the Cochrane Library on smoking-cessation methods and aids available in the Netherlands...